Company news

CytoSorbents Corporation news in 2019

CytoSorbents Corporation's news releases, calls and decks from 2019, newest first.

View company

CytoSorbents Reports Third Quarter 2019 Financial Results

November 4, 2019

CytoSorbents Announces Additions to its International Clinical Team

November 3, 2019

CytoSorbents Enrolls First Patient in TISORB Trial and Opens Operating Subsidiary in the United Kingdom

October 31, 2019

CytoSorbents to Report Q3 2019 Operating and Financial Results

October 29, 2019

CytoSorbents Awarded Approximately $3.0 Million by the U.S. Air Force to Advance Development of the K+ontrol System to Treat Severe Hyperkalemia

October 21, 2019

CytoSorb® Removal of Ticagrelor Intraoperatively Results in Projected Cost Savings of Approximately $5,000 in Each Patient Undergoing Emergency Cardiac Surgery

October 3, 2019

CytoSorbents Announces Positive Surgical Outcomes From CytoSorb Removal Of Antithrombotics In Emergency Cardiothoracic Surgery

October 1, 2019

CytoSorbents Highlights Survival Benefit of CytoSorb Therapy in Septic Shock

September 24, 2019

First Study to Evaluate CytoSorb in Cytokine Release Syndrome (CRS) Following CAR T-cell Immunotherapy to Commence

September 15, 2019

CytoSorbents Receives Renewal of CytoSorb® CE Mark Through May 2024 and Annual ISO 13485: 2016 Certification Through September 2022

August 14, 2019

CytoSorbents Expands CytoSorb Distribution in Latin America to Brazil, Colombia, and Costa Rica

August 12, 2019

CytoSorbents Reports Record Second Quarter 2019 Financial Results

August 5, 2019

CytoSorbents Announces Amendment to Loan Agreement with Bridge Bank, Receives an Additional $5 Million Cash from New Term Loan

August 4, 2019

CytoSorbents to Report Q2 2019 Operating and Financial Results

July 29, 2019

Decks in 2019